Celltrion
068270.KS
#810
Rank
โ‚น2.954 T
Marketcap
โ‚น12,955
Share price
-2.13%
Change (1 day)
18.33%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): โ‚น299.71

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น315.16. In 2025 the company made an earnings per share (EPS) of โ‚น299.22 an increase over its 2024 EPS that were of โ‚น113.49.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น299.710.16%
2025โ‚น299.22163.66%
2024โ‚น113.49-53.73%
2023โ‚น245.28-2.08%
2022โ‚น250.49-11.72%
2021โ‚น283.742.03%
2020โ‚น278.0982.8%
2019โ‚น152.1218.31%
2018โ‚น128.58-36.33%
2017โ‚น201.96161.25%
2016โ‚น77.312.86%
2015โ‚น75.1617.84%
2014โ‚น63.785.87%
2013โ‚น60.24-70.85%
2012โ‚น206.66134.09%
2011โ‚น88.2843.59%
2010โ‚น61.4874.49%
2009โ‚น35.24317.8%
2008โ‚น8.43-71.7%
2007โ‚น29.80